Report Id: PCMEDM319
Cognition and Memory Enhancement Drugs Market Size, By Product (Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall), By Application (Disease Treatment, Academic Performance, Athletic Performance), By Region Analysis - Global Forecast 2023-2028
The Global Cognition and Memory Enhancement Drugs Market is projected to reach US$ 9200 million by 2028, growing at a CAGR of 8.5%.
COVID-19 Impact Analysis Report
"Get Latest Updated Reports as per the COVID-19 Impact"
Infopedia: Access Our All Reports Online at Affordable Price
CLICK HEREMARKET SNAPSHOT
Major Players
- Pfizer
- Novartis
- AlternaScript
- Shire Pharmaceuticals
- Takeda Pharmaceutical Company
Study period:
Fastest Growing Market:
2023-2028
APAC
Base Year:
Largest Market:
2022
North America
CAGR:
8
REPORT DESCRIPTION
Cognition and memory enhancement drugs market size is predicted to witness high growth rate between 2022 and 2027. This high growth rate can be attributed to its utilization in treatment of multiple disorders including schizophrenia, attention deficit hyperactivity disorder, stroke, Alzheimer's disease, ageing, etc.
The Global Cognition and Memory Enhancement Drugs Market is projected to reach US$ 9200 million by 2028, growing at a CAGR of 8.5%.
Upsurge in geriatric population along with increasing prevalence of neurological & memory-related disorders will drive the cogition and memory enhancement drugs industry revenue generation over the forecast period. However, ethical issues relevant to the usage of such drugs may hamper the industry growth till 2027.
Global cognition and memory enhancement drugs market is segmented based on the product as, Aricept, Razadyne, Namenda, Exelon, Provigil, Ritalin, Adderall. On the basis of application, the global cognition and memory enhancement drugs market is segregated as Disease Treatment, Academic Performance, Athletic Performance. Disease treatment is expected to witness notable gains in the forecast years.
Global cognition and memory enhancement drugs market report covers various regions including North America, Europe, Asia Pacific, and Rest of World. The regional cognition and memory enhancement drugs market is further bifurcated for major countries including U.S., Canada, Germany, UK, France, Italy, China, India, Japan, Brazil, South Africa and others.
Competitive Rivalry
Global cognition and memory enhancement drugs market share consists of several players including Pfizer, Novartis, AlternaScript, Shire Pharmaceuticals, Takeda Pharmaceutical Company, Allergan plc, Eisai, Barr Pharmaceuticals, Johnson & Johnson and Cephalon.
The Cognition and Memory Enhancement Drugs Market has been segmented as below:
Cognition and Memory Enhancement Drugs Market, By Product
- Aricept
- Razadyne
- Namenda
- Exelon
- Provigil
- Ritalin
- Adderall
- Others
Cognition and Memory Enhancement Drugs Market, By Application
- Disease treatment
- Developmental conditions
- Neurodegenerative disorders
- Academic performance
- Athletic performance
- Others
Cognition and Memory Enhancement Drugs Market, By Region
- North America
- Europe
- Asia Pacific
- Rest of World
The report covers:
- Global cognition and memory enhancement drugs market estimates & forecast from 2021 to 2028, along with CAGR for 2023-2028
- Comparative market size analysis for 2022 vs 2028, with actual data for 2022, estimates for 2023 and forecast from 2024 to 2028
- Global cognition and memory enhancement drugs market trends, with detailed analysis on consumer trends & manufacturer trends
- Overview on supply analysis covering trends across raw material suppliers, technology providers and distributors
- Key areas of investments identifying market opportunities and challenges in forecast timeframe
- Competitive analysis of the industry players along with the overview on strategic management
- Comprehensive company profiles of the major industry players
Report scope:
The global cognition and memory enhancement drugs market report covers detailed study with the underlying influencing factors for the variations in the industry growth trends.
The report scope includes market analysis on regional as well as country level. The report also provides competitive landscape covering company market shares with detailed profiling for major revenue contributing companies.
The report covers a detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Pfizer, Novartis, AlternaScript, Shire Pharmaceuticals, Takeda Pharmaceutical Company, Allergan plc, Eisai, Barr Pharmaceuticals, Johnson & Johnson and Cephalon.
Reasons to Buy this Report:
- Gain comprehensive insights on the industry trends
- Identify industry opportunities and key growth segments
- Obtain complete market study on the cognition and memory enhancement drugs market
- Facilitate strategy planning for your company based on the industry dynamics
- Evaluate your competitor’s business segments and portfolios
Customization:
Customized report as per the requirement can be offered with appropriate recommendations
Below are our New Reports :-
Robotic Pharmacy Prescription Dispensing Systems Market
Laboratory Information Management System Market
1. Introduction
1.1. Key Points
1.2. Report Description
1.3. Markets Covered
1.4. Stakeholders
2. Research Methodology
2.1. Research Scope
2.2. Research Methodology
2.2.1. Market Research Process
2.2.2. Research Methodology
2.2.2.1. Secondary Research
2.2.2.2. Primary Research
2.2.2.3. Models for Estimation
2.3. Market Size Estimation
2.3.1. Bottom-Up Approach
2.3.2. Top-Down Approach
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Drivers
4.2.1. Rapidly aging population
4.2.2. High incidence of neurodegenerative disorders
4.2.3. Benefits of smart drugs
4.3. Restraints
4.3.1. Ethical issues
4.4. Opportunities
4.4.1. Effective strength of the drugs
4.5. Challenges
4.5.1. Trade policies
5. Cognition and Memory Enhancement Drugs Market, By Product
5.1. Key Points
5.2. Aricept
5.3. Razadyne
5.4. Namenda
5.5. Exelon
5.6. Provigil
5.7. Ritalin
5.8. Adderall
5.9. Others
6. Cognition and Memory Enhancement Drugs Market, By Application
6.1. Key Points
6.2. Disease treatment
6.2.1. Developmental conditions
6.2.2. Neurodegenerative disorders
6.3. Academic performance
6.4. Athletic performance
6.5. Others
7. Competitive Landscape
7.1. Introduction
7.2. Recent Developments
7.2.1. Mergers & Acquisitions
7.2.2. New Product Developments
7.2.3. Portfolio/Production Capacity Expansions
7.2.4. Joint Ventures, Collaborations, Partnerships & Agreements
7.2.5. Others
8. Company Profile
8.1. Pfizer
8.1.1. Company Overview
8.1.2. Product/Service Landscape
8.1.3. Financial Overview
8.1.4. Recent Developments
8.2. Novartis
8.2.1. Company Overview
8.2.2. Product/Service Landscape
8.2.3. Financial Overview
8.2.4. Recent Developments
8.3. AlternaScript
8.3.1. Company Overview
8.3.2. Product/Service Landscape
8.3.3. Financial Overview
8.3.4. Recent Developments
8.4. Shire Pharmaceuticals
8.4.1. Company Overview
8.4.2. Product/Service Landscape
8.4.3. Financial Overview
8.4.4. Recent Developments
8.5. Takeda Pharmaceutical Company
8.5.1. Company Overview
8.5.2. Product/Service Landscape
8.5.3. Financial Overview
8.5.4. Recent Developments
8.6. Allergan plc
8.6.1. Company Overview
8.6.2. Product/Service Landscape
8.6.3. Financial Overview
8.6.4. Recent Developments
8.7. Eisai, Barr Pharmaceuticals
8.7.1. Company Overview
8.7.2. Product/Service Landscape
8.7.3. Financial Overview
8.7.4. Recent Developments
8.8. Johnson & Johnson
8.8.1. Company Overview
8.8.2. Product/Service Landscape
8.8.3. Financial Overview
8.8.4. Recent Developments
8.9. Cephalon
8.9.1. Company Overview
8.9.2. Product/Service Landscape
8.9.3. Financial Overview
8.9.4. Recent Developments
The Cognition and Memory Enhancement Drugs Market has been segmented as below:
Cognition and Memory Enhancement Drugs Market, By Product
- Aricept
- Razadyne
- Namenda
- Exelon
- Provigil
- Ritalin
- Adderall
- Others
Cognition and Memory Enhancement Drugs Market, By Application
- Disease treatment
- Developmental conditions
- Neurodegenerative disorders
- Academic performance
- Athletic performance
- Others
Cognition and Memory Enhancement Drugs Market, By Region
- North America
- Europe
- Asia Pacific
- Rest of World
Got a question? We've got answers. If you have some other questions, see our support center.
What is the predicted growth rate of Cognition and memory enhancement drugs market?
The market is expected to grow at a CAGR of 8.5% during the study period (2023-2028)
How big is the Cognition and memory enhancement drugs market value?
The Global Cognition and Memory Enhancer Drugs Market is projected to reach US$ 9200 million by 2028
What is the segment’s covered for the Cognition and memory enhancement drugs market?
The segment included in the Cognition and memory enhancement drugs market is Product, Application and region.
Who are the major key vendors in the Cognition and memory enhancement drugs market?
Some key players operating in the Cognition and memory enhancement drugs market include Pfizer, Novartis, AlternaScript, Shire Pharmaceuticals, Takeda Pharmaceutical Company, Allergan plc, Eisai
What are the different forms of the report available?
We can offer several formats of the market research reports including,
• PDF
• PPT
• Spreadsheet/ Workbook
© 2020 COPYRIGHT : MARKET RESEARCH ENGINE